ADENOSINE DEAMINASE, ADA-PERITONEAL FLUID

Adenosine Deaminase (ADA) – Peritoneal Fluid is a biochemical test that measures adenosine deaminase activity in fluid collected from the peritoneal cavity. This fluid is also commonly called ascitic fluid. ADA is an enzyme involved in purine metabolism and is particularly associated with lymphocytes, which are white blood cells involved in cellular immune responses.

ADA activity may increase when lymphocytes are strongly activated, as can occur in tuberculosis affecting the lining of the abdominal cavity. The test is primarily used as a supportive investigation when peritoneal or abdominal tuberculosis is suspected. The result must be interpreted together with symptoms, imaging, fluid-cell analysis, microbiological testing, biopsy findings, and other clinical information.

Benefits of the Test

• Measures ADA activity directly in peritoneal or ascitic fluid.
• Provides supportive evidence during the evaluation of peritoneal tuberculosis.
• May help distinguish tuberculous ascites from certain non-tuberculous causes.
• Supports the assessment of unexplained fluid accumulation in the abdomen.
• Provides quantitative biochemical information for clinical interpretation.
• Can be performed with routine ascitic-fluid investigations.
• May guide the selection of additional microbiological or tissue tests.
• Supports faster clinical evaluation while culture or biopsy results are awaited.
• Can contribute to treatment planning when interpreted by a specialist.
• Requires only a portion of fluid collected during a medically indicated procedure.

Why Doctors Recommend This Test

Doctors may recommend this test when a patient has ascites accompanied by prolonged fever, abdominal pain, abdominal swelling, unexplained weight loss, reduced appetite, night sweats, or other findings that suggest abdominal tuberculosis. It may also be requested when imaging or routine ascitic-fluid analysis shows features requiring further evaluation. ADA testing is supportive and does not independently confirm tuberculosis.

Preparation Before Test

• Fasting may be required depending on the scheduled fluid-collection procedure.
• Follow the doctor’s instructions regarding food, water, and medicines.
• Inform the doctor about blood-thinning medicines or bleeding disorders.
• Do not stop prescribed medicines without medical advice.
• Inform the doctor if you are pregnant or may be pregnant.
• Share any history of tuberculosis or recent exposure to tuberculosis.
• Inform the doctor if anti-tuberculosis treatment has already been started.
• Carry previous ultrasound, CT, fluid-analysis, biopsy, or microbiology reports.
• The fluid must be collected by a trained medical professional using a sterile technique.
• Follow all instructions provided before and after the fluid-collection procedure.

Normal Reporting Time

The Adenosine Deaminase, ADA – Peritoneal Fluid test is generally reported within a few working days after the sample is received, processed, analysed, validated, and reviewed. The exact reporting time may vary according to the testing schedule, analytical method, sample condition, and laboratory workflow.

Who Should Take This Test?

This test may be recommended for:

• Patients with unexplained ascites or abdominal-fluid accumulation.
• Individuals being evaluated for suspected peritoneal tuberculosis.
• Patients with prolonged fever and abdominal swelling.
• Individuals with abdominal pain and unexplained weight loss.
• Patients with imaging findings suggestive of abdominal tuberculosis.
• Individuals with lymphocyte-predominant ascitic fluid.
• Patients with a history of tuberculosis or recent tuberculosis exposure.
• Individuals with inconclusive routine ascitic-fluid results.
• Patients requiring supportive testing while awaiting culture or biopsy findings.
• People specifically advised to undergo peritoneal-fluid ADA testing by a specialist.

Detailed Information

The peritoneum is a thin membrane that lines the abdominal cavity and covers many abdominal organs. Fluid may accumulate within this cavity due to liver disease, heart failure, kidney disease, infection, inflammation, pancreatitis, or malignancy. This abnormal fluid accumulation is called ascites.

Peritoneal tuberculosis occurs when Mycobacterium tuberculosis affects the peritoneal lining. It may cause abdominal swelling, pain, fever, weight loss, night sweats, reduced appetite, and changes in bowel habits. Symptoms can develop gradually and may resemble other abdominal conditions.

Adenosine deaminase participates in the metabolism of adenosine and deoxyadenosine. Increased ADA activity reflects activation of cell-mediated immunity, particularly the activity of T lymphocytes. Because tuberculosis can produce a strong cellular immune response, ADA levels may become elevated in fluid collected from an affected body cavity.

An increased peritoneal-fluid ADA result can support the possibility of tuberculous peritonitis, especially when the patient has compatible symptoms and lymphocyte-predominant ascites. However, the result is not completely specific for tuberculosis. Elevated ADA may also occur in bacterial infections, lymphoma, certain cancers, inflammatory disorders, and other conditions.

A low ADA result may make peritoneal tuberculosis less likely in an appropriate clinical setting, but it cannot completely exclude the disease. Results may be influenced by the patient’s immune status, stage of illness, previous treatment, sample quality, and analytical method.

The doctor may request total and differential cell counts, protein, albumin, glucose, lactate dehydrogenase, cytology, Gram staining, bacterial culture, acid-fast staining, mycobacterial culture, and molecular testing on the same fluid. Serum albumin may also be measured to calculate the serum-ascites albumin gradient.

Mycobacterial culture can provide microbiological confirmation but may take several weeks. Molecular tests may identify mycobacterial genetic material more rapidly, although sensitivity can vary in fluid samples. In some patients, laparoscopy and peritoneal biopsy may be required for histopathological examination and culture.

There is no single ADA value that should be applied to every patient or laboratory. Reference limits and clinical decision thresholds can vary according to the test method, local disease prevalence, patient population, and sample type. The result should be interpreted using the reference information printed on the individual report.

ADA testing does not identify drug resistance and cannot determine which anti-tuberculosis medicines will be effective. If tuberculosis is confirmed or strongly suspected, additional microbiological investigations may be needed to guide treatment.

At Focus Diagnostics, ADA Peritoneal Fluid testing is performed using established biochemical methods, appropriate fluid-handling procedures, and laboratory quality controls to provide reliable results for clinical interpretation.